Metaanalyses - Highest level of empirical evidence?

European Archives of Psychiatry and Clinical Neuroscience

Volumn 255, Issue 6, 2005, Pages 369-370

  Maier, Wolfgang ^a   Möller, Hans Jürgen ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL PRACTICE; EDITORIAL; EMPIRICAL RESEARCH; EVIDENCE BASED MEDICINE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; META ANALYSIS; METHODOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; STATISTICAL ANALYSIS;

CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; GUIDELINES; META-ANALYSIS;

EID: 29744433725     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-005-0607-5     Document Type: Editorial

References (11)

1. Anderson IM (1998) SSRIs versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety 7(Suppl 1):11-17
2. Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58:19-36
3. st century. J Clin Epidemiol 48:71-79
4. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 330:396-402
5. Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 321:1371-1376
6. Geddes JR, Harrison P, Freemantle N (2003) New generation versus conventional antipsychotics. Lancet 362:404
7. Gunnell D, Saperia J, Ashby D (2005) Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 330:385-389
8. Jüni P, Altman DG, Egger M (2001) Assessing the quality of controlled clinical trials. BMJ 323:42-46
9. Leucht S, Wahlbeck K, Hamann J, Kissling W (2003) New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 361:1581-1589
10. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B (2003) Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 326:1171-1173
11. Sterne JA, Gavaghan DJ, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53:1119-1129